Market Overview:
The global cancer supportive care market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, growing awareness about cancer supportive care, and technological advancements in the field of oncology. Based on type, the global cancer supportive care market is segmented into nonsteroidal erythropoietin stimulating agents, opioid analgesics, anti-inflammatory drugs, anti-infective drugs, bisphosphonates, anti-emetics drugs monoclonal antibodies and granulocyte colony stimulating factor (GCSF). Nonsteroidal erythropoietin stimulating agents are expected to be the fastest growing segment during the forecast period owing to their ability to improve red blood cell count and hemoglobin levels in patients with anemia caused by chemotherapy or radiation therapy. Based on application, lung cancer is estimated to be the largest segment in 2018 followed by breast cancer.
Product Definition:
Cancer supportive care is the term given to a range of interventions that are used to improve the quality of life for people living with cancer. It includes treatments and services aimed at preventing or managing the side effects of cancer and its treatment, such as pain relief, nausea and vomiting control, and emotional support.
Nonsteroidal Erythropoietin Stimulating Agents:
Nonsteroidal erythropoietin (NSE) stimulating agents are used to stimulate the immune system to produce more red blood cells. The normal function of this protein is to help the body get enough oxygen levels by removing worn out or damaged blood cells from the circulation. NSE is produced naturally in the kidney, liver and gut of humans; however, in some people it does not function normally due to a lack of certain proteins that are supposed to help regulate its production.
Opioid Analgesics:
Analgesics is a drug that reduces or eliminates the pain. The most commonly used analgesic in cancer supportive care is opioids, which are also known as pain-killers. Opioids are semi-synthetic and synthetic drugs that bind to opioid receptors (ORs) in the brain stem to reduce or eliminate chronic pain. Some of the commonly used opioids include hydrocodone, oxycodone, and fentanyl; they are all opioid agonists.
Application Insights:
The lung cancer segment dominated the market in 2017 owing to the increasing prevalence of the disease. According to data published by WHO, in 2018, around 210,170 new cases of lung cancer were reported worldwide. In addition, as per American Cancer Society (ACS), an estimated 120,000 people are diagnosed with non-small cell lung cancer and 60,000 die from this disease annually. Thus, rising incidence coupled with high mortality rates is expected to drive demand for oncology supportive care products during the forecast period.
Breast cancer is also anticipated to witness lucrative growth over the forecast period due largely to increased awareness about early detection and treatment options available for this condition.S women develop invasive breast carcinoma which accounts for 40% of all female cancers and 2 out of 3 breast carcinomas occur in women above 50 years age group globally1!.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of supportive care centers and organizations, such as American Cancer Society (ACS), which provide free information regarding cancer-related topics and support services to patients throughout North America. In addition, government initiatives that offer financial assistance for medical treatments are also expected to drive growth over the forecast period. For instance, under Medicare Part B coverage is provided for diagnostic tests recommended by oncologists or primary care physicians that are considered reasonable by Medicare.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global cancer supportive care market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 609,640 people will die from this disease. This high incidence rate is expected to drive demand for various types of cancer supportive care products and services in the coming years.
- Growing awareness about available treatments: There has been a growing awareness among patients about available treatments for different types of cancers in recent years. This has led to an increase in demand for various types of cancer supportive care products and services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Supportive Care Market Research Report
By Type
Nonsteroidal Erythropoietin Stimulating Agents, Opioid Analgesics, Anti-Imflammatory Drugs, Anti-Infective Drugs, Bisphosphonates, Anti-Emetics Drugs, Monoclonal Antibodies, Granulocyte Colony Stimulating Factor
By Application
Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovarian Cancer, Melanoma, Others
By Companies
Amgen, Helsinn Healthcare, Johnson &Johnson, Merck, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, TESARO, Teva Pharmaceutical Industries, Amgen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Supportive Care Market Report Segments:
The global Cancer Supportive Care market is segmented on the basis of:
Types
Nonsteroidal Erythropoietin Stimulating Agents, Opioid Analgesics, Anti-Imflammatory Drugs, Anti-Infective Drugs, Bisphosphonates, Anti-Emetics Drugs, Monoclonal Antibodies, Granulocyte Colony Stimulating Factor
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovarian Cancer, Melanoma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Helsinn Healthcare
- Johnson &Johnson
- Merck
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Novartis
- TESARO
- Teva Pharmaceutical Industries
- Amgen
Highlights of The Cancer Supportive Care Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nonsteroidal Erythropoietin Stimulating Agents
- Opioid Analgesics
- Anti-Imflammatory Drugs
- Anti-Infective Drugs
- Bisphosphonates
- Anti-Emetics Drugs
- Monoclonal Antibodies
- Granulocyte Colony Stimulating Factor
- By Application:
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Leukemia
- Ovarian Cancer
- Melanoma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Supportive Care Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cancer supportive care is a type of care that helps people with cancer live as comfortably and safely as possible. It includes providing support during treatment, after treatment, and during recovery. Cancer supportive care can also include helping people maintain their quality of life.
Some of the key players operating in the cancer supportive care market are Amgen, Helsinn Healthcare, Johnson &Johnson, Merck, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, TESARO, Teva Pharmaceutical Industries, Amgen.
The cancer supportive care market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Supportive Care Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cancer Supportive Care Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cancer Supportive Care Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cancer Supportive Care Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cancer Supportive Care Market Size & Forecast, 2018-2028
4.5.1 Cancer Supportive Care Market Size and Y-o-Y Growth
4.5.2 Cancer Supportive Care Market Absolute $ Opportunity
Chapter 5 Global Cancer Supportive Care Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cancer Supportive Care Market Size Forecast by Type
5.2.1 Nonsteroidal Erythropoietin Stimulating Agents
5.2.2 Opioid Analgesics
5.2.3 Anti-Imflammatory Drugs
5.2.4 Anti-Infective Drugs
5.2.5 Bisphosphonates
5.2.6 Anti-Emetics Drugs
5.2.7 Monoclonal Antibodies
5.2.8 Granulocyte Colony Stimulating Factor
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cancer Supportive Care Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cancer Supportive Care Market Size Forecast by Applications
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Prostate Cancer
6.2.4 Liver Cancer
6.2.5 Bladder Cancer
6.2.6 Leukemia
6.2.7 Ovarian Cancer
6.2.8 Melanoma
6.2.9 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Supportive Care Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Supportive Care Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cancer Supportive Care Analysis and Forecast
9.1 Introduction
9.2 North America Cancer Supportive Care Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cancer Supportive Care Market Size Forecast by Type
9.6.1 Nonsteroidal Erythropoietin Stimulating Agents
9.6.2 Opioid Analgesics
9.6.3 Anti-Imflammatory Drugs
9.6.4 Anti-Infective Drugs
9.6.5 Bisphosphonates
9.6.6 Anti-Emetics Drugs
9.6.7 Monoclonal Antibodies
9.6.8 Granulocyte Colony Stimulating Factor
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cancer Supportive Care Market Size Forecast by Applications
9.10.1 Lung Cancer
9.10.2 Breast Cancer
9.10.3 Prostate Cancer
9.10.4 Liver Cancer
9.10.5 Bladder Cancer
9.10.6 Leukemia
9.10.7 Ovarian Cancer
9.10.8 Melanoma
9.10.9 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cancer Supportive Care Analysis and Forecast
10.1 Introduction
10.2 Europe Cancer Supportive Care Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cancer Supportive Care Market Size Forecast by Type
10.6.1 Nonsteroidal Erythropoietin Stimulating Agents
10.6.2 Opioid Analgesics
10.6.3 Anti-Imflammatory Drugs
10.6.4 Anti-Infective Drugs
10.6.5 Bisphosphonates
10.6.6 Anti-Emetics Drugs
10.6.7 Monoclonal Antibodies
10.6.8 Granulocyte Colony Stimulating Factor
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cancer Supportive Care Market Size Forecast by Applications
10.10.1 Lung Cancer
10.10.2 Breast Cancer
10.10.3 Prostate Cancer
10.10.4 Liver Cancer
10.10.5 Bladder Cancer
10.10.6 Leukemia
10.10.7 Ovarian Cancer
10.10.8 Melanoma
10.10.9 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cancer Supportive Care Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cancer Supportive Care Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cancer Supportive Care Market Size Forecast by Type
11.6.1 Nonsteroidal Erythropoietin Stimulating Agents
11.6.2 Opioid Analgesics
11.6.3 Anti-Imflammatory Drugs
11.6.4 Anti-Infective Drugs
11.6.5 Bisphosphonates
11.6.6 Anti-Emetics Drugs
11.6.7 Monoclonal Antibodies
11.6.8 Granulocyte Colony Stimulating Factor
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cancer Supportive Care Market Size Forecast by Applications
11.10.1 Lung Cancer
11.10.2 Breast Cancer
11.10.3 Prostate Cancer
11.10.4 Liver Cancer
11.10.5 Bladder Cancer
11.10.6 Leukemia
11.10.7 Ovarian Cancer
11.10.8 Melanoma
11.10.9 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cancer Supportive Care Analysis and Forecast
12.1 Introduction
12.2 Latin America Cancer Supportive Care Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cancer Supportive Care Market Size Forecast by Type
12.6.1 Nonsteroidal Erythropoietin Stimulating Agents
12.6.2 Opioid Analgesics
12.6.3 Anti-Imflammatory Drugs
12.6.4 Anti-Infective Drugs
12.6.5 Bisphosphonates
12.6.6 Anti-Emetics Drugs
12.6.7 Monoclonal Antibodies
12.6.8 Granulocyte Colony Stimulating Factor
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cancer Supportive Care Market Size Forecast by Applications
12.10.1 Lung Cancer
12.10.2 Breast Cancer
12.10.3 Prostate Cancer
12.10.4 Liver Cancer
12.10.5 Bladder Cancer
12.10.6 Leukemia
12.10.7 Ovarian Cancer
12.10.8 Melanoma
12.10.9 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cancer Supportive Care Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cancer Supportive Care Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cancer Supportive Care Market Size Forecast by Type
13.6.1 Nonsteroidal Erythropoietin Stimulating Agents
13.6.2 Opioid Analgesics
13.6.3 Anti-Imflammatory Drugs
13.6.4 Anti-Infective Drugs
13.6.5 Bisphosphonates
13.6.6 Anti-Emetics Drugs
13.6.7 Monoclonal Antibodies
13.6.8 Granulocyte Colony Stimulating Factor
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cancer Supportive Care Market Size Forecast by Applications
13.10.1 Lung Cancer
13.10.2 Breast Cancer
13.10.3 Prostate Cancer
13.10.4 Liver Cancer
13.10.5 Bladder Cancer
13.10.6 Leukemia
13.10.7 Ovarian Cancer
13.10.8 Melanoma
13.10.9 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Supportive Care Market: Competitive Dashboard
14.2 Global Cancer Supportive Care Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amgen
14.3.2 Helsinn Healthcare
14.3.3 Johnson &Johnson
14.3.4 Merck
14.3.5 F. Hoffmann-La Roche
14.3.6 GlaxoSmithKline
14.3.7 Novartis
14.3.8 TESARO
14.3.9 Teva Pharmaceutical Industries
14.3.10 Amgen
